Table 3.
Unadjusted and adjusted odds ratios of mRS 3–6 in patients categorized by plasma YKL-40 percentiles
| 3 months |
6 months |
12 months |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| patients, n (%) | OR (unadjusted) | OR (adjusteda) | patients, n (%) | OR (unadjusted) | OR (adjusteda) | patients, n (%) | OR (unadjusted) | OR (adjusteda) | |
| 0–33% | 226 (8.6) | Reference | 184 (7.1) | Reference | 174 (6.8) | Reference | |||
| 34–66% | 328(12.5) | 1.51 (1.27–1.81) | 1.16(0.95–1.42) | 274(10.5) | 1.54 (1.27–1.87) | 1.09 (0.88–1.35) | 271 (10.5) | 1.61 (1.32–1.96) | 1.11 (0.89–1.38) |
| 67–90% | 303 (16.0) | 2.01 (1.67–2.41) | 1.18(0.95–1.47) | 280(14.8) | 2.28 (1.87–2.78) | 1.21 (0.96–1.52) | 293(15.7) | 2.57 (2.11–3.14) | 1.30(1.03–1.63) |
| 91–100% | 179(22.8) | 3.13(2.52–3.88) | 1.15 (0.88–1.52) | 174 (22.2) | 3.75 (2.99–4.70) | 1.26 (0.95–1.67) | 187 (24.0) | 4.36 (3.48–5.47) | 1.42(1.08–1.88) |
OR, odds ratios.
a
Adjusted for: age, sex, smoking, drinking, hypertension, diabetes mellitus, LDL, C-reactive protein, NIHSS, medicine at discharge (antiplatelet, anticoagulant, lipid-lowering, hypoglycemic, antihypertensive medicines), complications (respiratory, liver, urinary, and bleeding diseases).